Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vitalhub Corp T.VHI

Alternate Symbol(s):  VHIBF

VitalHub Corp. is a Canada-based software company. The Company offers software for health and human service providers designed to simplify the user experience and optimize outcomes. It offers a comprehensive suite of software-as-a-service (SaaS) solutions, which include electronic health record (EHR), case management, care coordination, and optimization; patient flow, operational visibility, and patient journey optimization, and workforce automation. Its solutions include Alamac, Beautiful Information, Hicom, Intouch with Health, MCAP, Oculys, SHREWD, Synopsis, B Care, CaseWORKS, Pirouette, S12 Solutions and TREAT. Its clients include hospitals, regional health authorities, mental health and addictions services providers for children and adults, long-term care facilities, home health agencies, correctional services, and community and social services providers. It serves clients across Canada, the United States, the United Kingdom, Australia, the Middle East, and Europe.


TSX:VHI - Post by User

Post by Possibleidiot01on Aug 14, 2023 7:29pm
170 Views
Post# 35588028

Trevor Rose's Insights - BUY

Trevor Rose's Insights - BUY
BUY
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

2Q sales rose 38% to $13.1M; margins dipped to 81% from 83% due to an increase in lower margin service revenue. EBITDA nearly doubled to $1.9M. Net income was $0.72M from a loss last year. Cash was $22M. Results look good to us; Cormark raised its target price slightly. EPS is predicted to double in 2024, with slower growth following the next year. 
Unlock Premium - Try 5i Free

Healthcare
$2.980
Unknown

<< Previous
Bullboard Posts
Next >>